Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
Rhea-AI Summary
Resmed (NYSE: RMD, ASX: RMD) announced a comprehensive brand evolution to unify its portfolio under a single identity, marking a significant shift in its 35-year history. The health technology company, focused on sleep, breathing, and home care, aims to consolidate its brands, products, and services over the next couple of years.
The rebranding includes a new visual identity, logo, and brand voice, positioning Resmed as an approachable health technology leader. This evolution coincides with three major initiatives: a U.S. consumer campaign to destigmatize CPAP therapy, a primary care physician education campaign for earlier sleep apnea diagnosis, and a sleep health awareness campaign in Asia Pacific and Europe.
According to Resmed's 2025 Global Sleep Survey, one-third of respondents report sleep difficulties, with 34% having trouble falling asleep and 29% staying asleep. The company estimates that over 2.3 billion people worldwide suffer from sleep apnea, insomnia, COPD, or other respiratory insufficiency.
Positive
- Strategic brand consolidation to strengthen market position and streamline operations
- Launch of three major market initiatives to expand awareness and treatment adoption
- Large addressable market of 2.3+ billion potential patients globally
Negative
- None.
News Market Reaction – RMD
In the trading session that priced this news, RMD declined 4.58%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Brand Evolution Unites Brands Under One Resmed Identity to Make Better Sleep and Breathing Health More Accessible to Everyone
SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a comprehensive brand evolution designed to unify its brand portfolio to serve more people and healthcare providers worldwide and reflect growing direct to consumer engagement.
For 35 years, Resmed has pioneered innovations in respiratory therapy, including CPAP therapy and digital health solutions. The company’s last major brand update in 2014 marked its shift to connectivity, introducing cloud-connected medical devices that revolutionized sleep apnea therapy. Today, Resmed is taking the next step – transforming into a fully unified health technology brand that serves millions of consumers, healthcare professionals, and software users worldwide.
An estimated 2.3+ billion people worldwide suffer from sleep apnea, insomnia, COPD, or other respiratory insufficiency. 1 2 3 Additionally, Resmed’s 2025 Global Sleep Survey highlights the widespread impact of poor sleep, with one-third of respondents reporting sleep difficulties, including trouble falling asleep (
“We are at a pivotal moment in health – sleep and breathing health are gaining the attention once reserved for diet and exercise, with consumers taking a more proactive role in their care,” said Katrin Pucknat, Resmed’s Chief Marketing Officer. “Our brand evolution is more than a new look – it’s a bold step forward in our strategy to make sleep and breathing health a mainstream priority in global healthcare.”
As part of the brand evolution, Resmed plans to consolidate its brands, products, and services under a single Resmed brand over the next couple of years, creating a more streamlined view for both consumers and healthcare providers. This transformation is accompanied by a new visual identity, redesigned logo, and refreshed brand voice, reinforcing Resmed’s position as an approachable, people-centered, and forward-thinking health technology company.
The brand evolution aligns with Resmed’s mission to create life-changing health technologies that people love and coincides with three major market-facing initiatives aimed at reshaping perceptions of sleep therapy and expanding awareness of sleep apnea treatment:
- The company’s first U.S. consumer campaign aimed at destigmatizing CPAP therapy and positioning sleep health as more approachable
- A targeted primary care physician (PCP) education campaign starting in the U.S. to help drive earlier diagnosis and intervention for sleep apnea
- A sleep health awareness campaign in key markets in Asia Pacific and Europe focused on helping to overcome the barriers to seeking treatment for sleep apnea
“Resmed has evolved beyond its origins as a CPAP device and mask manufacturer. Our new brand reflects who we are today – a global leader in health technology, delivering solutions that help people rise to their full potential through better sleep and breathing, with care delivered in the home,” said Mick Farrell, Resmed’s Chairman & CEO. “With this evolution, we are reaffirming our commitment to empowering 500 million people worldwide to achieve their full health potential by 2030 and changing the delivery of healthcare.”
To learn more about Resmed’s brand evolution, visit resmed.com/brand-evolution.
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
| For Media | For Investors |
| Julia Moser | Mike Ott or Wendy Wilson |
| news@resmed.com | investorrelations@resmed.com |
_________________________________
1 Benjafield et al Lancet Respir Med 2019
2 Benjafield et al Sleep Med (suppl) 2024
3 Boers et al JAMA Network Open 2023
4 Based on over 30,000 respondents across 13 markets surveyed as part of the ResMed 2025 Global Sleep Survey between December 12-28, 2024)
